Injective INJ
Current Price
$3.84 +0.17%
$0.1400 Daily Range (3.65%)
$3.80$3.94
$76.89M Daily Volume
961 BTC
Vol/MktCap: 20.00%
Market Performance
0.20% Relative BTC Volume
The total volume of Injective is $76.89M over the past 24 hours, compared to $38.45B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.87 -0.66%
13 SMA $3.87 -0.89%
21 SMA $3.87 -0.71%
55 SMA $3.85 -0.14%
144 SMA $3.78 +1.55%
Price Performance
-0.17% 1 Hour Change
$3.84 from $3.85
+11.77% 7 Day Change
$0.4519 from $3.39
+16.44% 14 Day Change
$0.6314 from $3.21
+35.42% 30 Day Change
$1.36 from $2.48
All Time High
March 14, 2024
$52.62 -92.69%
-$48.77 vs. now
24H Change
727.27K USD +0.19%
9 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
19.87M INJ
traded over past 24 hours
19.87% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.92, showing a slight 24-hour change of 0.35%. The asset has a daily range of $3.80 to $3.94, indicating moderate volatility with a 24-hour trading volume of approximately 66.3 million, reflecting a healthy market interest with a volume-to-market cap ratio of 16.89%.
The short-term moving averages indicate a bullish trend, with the 8 SMA at $3.88 showing a gain of 1.06% and the 55 SMA at $3.83 reflecting a 2.34% increase. The 1-hour and 7-day Relative Strength Index (RSI) both stand at 56, suggesting that INJ is neither overbought nor oversold, maintaining a balanced momentum.
Over the past week, INJ has seen a price increase of approximately 12.93%, while the 14-day and 30-day changes are even more robust at 20.33% and 38.10%, respectively. This sustained growth indicates a strong bullish sentiment in the market, likely driven by positive developments or increased adoption.
The all-time high for INJ is significantly higher at $52.62, reached on March 14, 2024, indicating substantial potential for future price appreciation. Given the current technical indicators, strong performance over the past month, and supportive trading volume, the outlook appears favorable for Injective.
Considering the technical analysis, bullish momentum in the short-term moving averages, and favorable price changes, a Buy rating is warranted. The current price level offers an attractive entry point, especially given the asset’s historical potential and positive market dynamics.
The short-term moving averages indicate a bullish trend, with the 8 SMA at $3.88 showing a gain of 1.06% and the 55 SMA at $3.83 reflecting a 2.34% increase. The 1-hour and 7-day Relative Strength Index (RSI) both stand at 56, suggesting that INJ is neither overbought nor oversold, maintaining a balanced momentum.
Over the past week, INJ has seen a price increase of approximately 12.93%, while the 14-day and 30-day changes are even more robust at 20.33% and 38.10%, respectively. This sustained growth indicates a strong bullish sentiment in the market, likely driven by positive developments or increased adoption.
The all-time high for INJ is significantly higher at $52.62, reached on March 14, 2024, indicating substantial potential for future price appreciation. Given the current technical indicators, strong performance over the past month, and supportive trading volume, the outlook appears favorable for Injective.
Considering the technical analysis, bullish momentum in the short-term moving averages, and favorable price changes, a Buy rating is warranted. The current price level offers an attractive entry point, especially given the asset’s historical potential and positive market dynamics.
Updated 389 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Arbitrum vote to release $71M in frozen Kelp exploit ETH set to pass
The Snapshot vote would move the recovery effort toward a binding onchain Arbitrum governance proposal.

The $700 million migration: Why Solv Protocol is ditching LayerZero for Chainlink
The combined migrations by Solv and Kelp shift nearly $1 billion in assets to Chainlink's CCIP, reflecting an industry "flight to quality."

Bitcoin tests Bollinger Bands breakout as creator flips bullish on BTC
A related MVRV indicator hit overheated levels last seen before bitcoin's late-2024 push to $100,000.

Strategy Selling Bitcoin ‘Isn’t A Bad Thing,’ Samson Mow Says
Samson Mow has pushed back against the idea that Strategy selling Bitcoin would necessarily undermine its treasury thesis, arguing that Bitcoin treasury companies need…